ANI Pharmaceuticals (ANIP) Stock Highlights

61.05 | +1.65%

2024-09-19 03:10:17

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Propafenone, and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Statistics

Range Today

60.35 62.89

Volume Today 364.5K

Range 1 Year

48.2 70.81

Volume 1 Year 49.01M

Range 3 Year

22.31 70.81

Volume 3 Year 109.82M

Range 10 Year

22.31 86.96

Volume 10 Year 395.81M

Highlights

Market Capitalization 1.23B (small)

Floating Shares 15.9M

Current Price 61.05

Price To Earnings 47.75

Price To Revenue 2.25

Price To Book 2.51

Earnings Per Share 1.19

Payout Ratio 0%

Performance

Latest +1.65%

1 Month +1.46%

3 Months -1.25%

6 Months -7.56%

1 Year -1.9%

3 Years +115.27%

5 Years -17.33%

10 Years +103.43%

Benchmarks

Market Capitalization

19 / 54

Gross Profits

22 / 39

Total Revenue

24 / 50

Total Rank

27 / 54

Free Cashflow

17 / 54

Performance 5 years

20 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.